$120.85$150.99
Prepare to embark on a sensory journey with the Bosco Apple, a fruit that transcends the ordinary and promises an unparalleled taste experience. These apples are nothing short of nature’s masterpiece, celebrated for their distinctive blend of flavors and their captivating visual allure.
Availability: In Stock
₹171
INTRODUCTION ABEL CT 12.5MG is a fixed-dose combination of Azilsartan and Chlorthalidone which belongs to the group of medicines called Antihypertensive agents. It is used in adults to treat hypertension. Hypertension (also known as high blood pressure) is a medical condition in which the forc...
ABEL CT 12.5MG is a fixed-dose combination of Azilsartan and Chlorthalidone which belongs to the group of medicines called Antihypertensive agents. It is used in adults to treat hypertension. Hypertension (also known as high blood pressure) is a medical condition in which the force of the blood exerted against the walls of the artery remains very high, and as a result it may lead to severe damage to the blood vessels supplying several organs, like heart, kidney, or brain.
Azilsartan is an angiotensin II receptor blocker. It acts by relaxing the blood vessels supplying the vital organs. Chlorthalidone is a thiazide-diuretic. It acts by increasing the removal of water and certain electrolytes (sodium and chloride) from the body in the form of urine which eventually reduces blood volume. Collectively, they improve blood flow through the blood vessels and reduces the elevated blood pressure.
While undergoing therapy with ABEL CT 12.5MG your doctor will regularly monitor your blood pressure, kidney function, blood sugar, cholesterol or uric acid levels and electrolyte profile (sodium, potassium, and magnesium levels) to avoid the risk of unwanted side effects.
Before taking ABEL CT 12.5MG inform your doctor if you have any heart, kidney, or liver problems. You must also inform your doctor if you have diabetes related kidney problems, gout, or are severely dehydrated (due to vomiting or diarrhea).
ABEL CT 12.5MG is strictly not recommended for use in pregnant or breastfeeding women. Women taking ABEL CT 12.5MG must inform their doctor immediately if they become pregnant while undergoing therapy with ABEL CT 12.5MG.
ABEL CT 12.5MG may make you feel dizzy or faint. Therefore, be cautious while you drive or operate any tools that requires proper attention. Other common side effects of ABEL CT 12.5MG are low blood potassium levels, tiredness, or muscle spasms. Consult your doctor if any of these side effect worsens.
ABEL CT 12.5MG effectively controls blood pressure. It contains azilsartan and chlorthalidone. Azilsartan blocks the actions of a peptide hormone called angiotensin-II that increases blood pressure. This makes the blood vessels to relax and improves blood flow within them. Chlorthalidone increases the excretion of water and electrolytes (sodium and chloride) from the body in the form of urine. This reduces blood volume which makes the blood to be pumped easier by the heart with less pressure. Collectively they reduces blood pressure.
Take ABEL CT 12.5MG as directed by the physician. Swallow ABEL CT 12.5MG with a glass of water. Do not crush or chew the medicine. ABEL CT 12.5MG can be taken with or without meals.
Your doctor will decide the correct dose and for how long ABEL CT 12.5MG must be taken depending upon your age, body weight and disease condition. Do not stop taking ABEL CT 12.5MG without consulting your doctor.
Stop taking ABEL CT 12.5MG and contact your doctor immediately if you experience any of the following side effects:
Dizziness:
Try to rest and relax. Get enough sleep. Avoid driving or operating any tools or machines completely while you are feeling dizzy. Do not consume excessive alcohol, as it could aggravate your dizziness. Consult your doctor if your dizziness worsens.
Nausea and Vomiting:
Take ABEL CT 12.5MG with or just after a meal or a snack. Stick to simple meals. Avoid eating rich or spicy food. Consult your doctor if your nausea worsens.
ABEL CT 12.5MG is strictly not recommended for use in pregnant women as it may cause serious harm to the unborn baby. Therefore, consult your doctor before taking it. Women taking ABEL CT 12.5MG must inform their doctor immediately if they become pregnant while undergoing therapy with ABEL CT 12.5MG.
ABEL CT 12.5MG is not recommended for use in breast feeding women. Therefore, consult your doctor before taking it.
Do not drive or operate any tools or machines if you feel dizzy after taking ABEL CT 12.5MG.
Avoid consumption of alcohol while undergoing therapy ABEL CT 12.5MG as it may make you feel dizzy or drowsy.
ABEL CT 12.5MG is not recommended for use in patients with severe kidney diseases or problems in passing urine. It should be used with caution in patients with other kidney problems (such as dialysis or any recent kidney transplant). Therefore, consult your doctor before taking it.
ABEL CT 12.5MG is not recommended for use in patients with severe liver diseases. It should be used with caution in patients with other liver problems. Therefore, consult your doctor before taking it.
Do not take ABEL CT 12.5MG if you are allergic to Azilsartan or Chlorthalidone.
ABEL CT 12.5MG should be used with caution in patients with heart problems (such as heart attack or failure, low blood pressure, narrowing or heart valves or increase in thickness of heart muscles). Therefore, consult your doctor before taking it.
ABEL CT 12.5MG is not recommended for use if you:
Before taking ABEL CT 12.5MG, inform your doctor if you:
Use in pediatrics:
ABEL CT 12.5MG should not be used in children and adolescents (below 18 years) due to lack of safety data. Therefore, consult your doctor before taking it.
Use in geriatrics:
ABEL CT 12.5MG should be used with caution in elderly patients. Therefore, consult your doctor before taking it.
A. Drug-Drug Interaction:
Before taking ABEL CT 12.5MG, inform your doctor if you are taking any of the following medicines such as:
Overdosage:
If you or anyone else accidentally took more ABEL CT 12.5MG, consult your doctor immediately. Symptoms of overdosage might include feeling dizzy or faint.
Drug | : |
Azilsartan, Chlorthalidone |
Pharmacological Category | : |
Angiotensin Receptor Blockers, Thiazide Diuretics |
Therapeutic Indication | : |
Hypertension |
Dosage Forms | : |
Tablet |
What are the uses of ABEL CT 12.5MG?
ABEL CT 12.5MG is used in adults to treat hypertension. It effectively controls blood pressure, where azilsartan acts by relaxing the blood vessels and chlorthalidone acts by increasing the excretion of sodium and water from the body in the form of urine. Collectively, they relax blood vessels, improves blood flow and reduces blood pressure.
What type of a drug is ABEL CT 12.5MG?
ABEL CT 12.5MG is an antihypertensive medicine used to reduce elevated blood pressure. It contains a combination of two medicines called azilsartan and chlorthalidone. Azilsartan is an angiotensin II receptor blocker and chlorthalidone is a thiazide-diuretic. They both acts together in reducing blood pressure.
What are the side effects of ABEL CT 12.5MG?
ABEL CT 12.5MG may make you feel dizzy or faint. Therefore, be cautious while you drive or operate any tools that requires proper attention. Other common side effects of ABEL CT 12.5MG are low blood potassium levels, tiredness, or muscle spasms. Consult your doctor if any of these side effect worsens.
Can the use of ABEL CT 12.5MG cause kidney problems?
Yes. The use of ABEL CT 12.5MG may affect your kidney functions. It is strictly not recommended for use in patients with severe kidney problems. It should be used with caution in patients with other kidney problems (such as dialysis or any recent kidney transplant). Therefore, consult your doctor before taking ABEL CT 12.5MG as a precaution.
Can ABEL CT 12.5MG reduce blood pressure?
Yes. ABEL CT 12.5MG effectively controls blood pressure in patients with hypertension.
What happens when I stop taking ABEL CT 12.5MG?
Do not stop taking ABEL CT 12.5MG without consulting your doctor as your blood pressure may raise once again. Make sure to take ABEL CT 12.5MG for the stipulated duration recommended by your doctor to achieve maximum results.
What is the best time to take ABEL CT 12.5MG?
ABEL CT 12.5MG can be taken with or without meals. Your doctor will decide the best time for you to take ABEL CT 12.5MG based on your age, body weight and disease condition.
How long will it take for ABEL CT 12.5MG to show the results?
You might be able to notice a reduction in your blood pressure within 1-2 weeks of starting therapy with ABEL CT 12.5MG. However, it may take around 4 weeks for you to notice the maximum benefits. Therefore, continue to take ABEL CT 12.5MG as advised by your doctor.
What to do if I forgot to take a dose of ABEL CT 12.5MG?
If you have missed a dose of ABEL CT 12.5MG, take it as soon as you remember. However, if it is time for the next dose of ABEL CT 12.5MG, skip the missed dose and take the next one regularly. Do not take a double dose of ABEL CT 12.5MG to compensate the missed ones.
1. K.D. Tripathi. Diuretics. Antihypertensives. Essential of Medical Pharmacology. 7th Edition. 2013. Page: 583-586 and 561.
2. David J. Collier MD, PhD, Attila Juhasz MD, PhD, Enrico Agabiti-Rosei MD, PhD, Eric Lloyd MS, Michie Hisada MD, MPH, ScD, Lin Zhao PhD, Stuart Kupfer MD, Mark J. Caulfield MD. Efficacy and safety of azilsartan medoxomil/chlortalidone fixed-dose combination in hypertensive patients uncontrolled on azilsartan medoxomil alone: A randomized trial. Wiley Online Library. October 2018. [Accessed on 23rd June 2022] https://onlinelibrary.wiley.com/doi/10.1111/jch.13376
3. Ipca Laboratories. Optimising TRIUMPH with 6·25 mg chlorthalidone. The Lancet.com. February 2020. [Accessed on 23rd June 2022] https://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(19)30535-2.pdf
4. Takeda Ireland Limited. Health Products Regulatory Authority (HPRA). [Revised in December 2021] [Accessed on 23rd June 2022] https://www.hpra.ie/img/uploaded/swedocuments/cf80a3a8-cab0-4606-85da-ef6eb00fe5ee.pdf
5. Takeda Pharmaceuticals America, Inc. U.S. Food & Drug Administration. [Revised in December 2011] [Accessed on 23rd June 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202331lbl.pdf